1. Adelman, David E. 2005. A fallacy of the commons in biotech patent policy. Berkeley Technology Law Journal 20: 985.
2. Adelman, David E., and Kathryn L. DeAngelis. 2007. Patent metrics: The mismeasure of innovation in the biotech patent debate. Texas Law Review 85: 1677.
3. Allison, Malorye. 2011. Myriad decision reassures biotechs but diagnostics still murky. Nature Biotechnology 29: 771.
4. Amani, Bita. 2009. State agency and the patenting of life in international law: Merchants and missionaries in a global society. Farnham/Burlington: Ashgate.
5. Ancarani, Vittorio. 2008. The politics of the human genome project. Do institutions matter? Roma: Aracne.